1. Home
  2. EVAX vs ADXN Comparison

EVAX vs ADXN Comparison

Compare EVAX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • ADXN
  • Stock Information
  • Founded
  • EVAX 2008
  • ADXN 2002
  • Country
  • EVAX Denmark
  • ADXN Switzerland
  • Employees
  • EVAX N/A
  • ADXN N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVAX Health Care
  • ADXN Health Care
  • Exchange
  • EVAX Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • EVAX 8.7M
  • ADXN 8.0M
  • IPO Year
  • EVAX 2021
  • ADXN N/A
  • Fundamental
  • Price
  • EVAX $2.62
  • ADXN $7.59
  • Analyst Decision
  • EVAX Strong Buy
  • ADXN Strong Buy
  • Analyst Count
  • EVAX 3
  • ADXN 1
  • Target Price
  • EVAX $33.33
  • ADXN $30.00
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • ADXN 24.6K
  • Earning Date
  • EVAX 03-26-2025
  • ADXN 03-24-2025
  • Dividend Yield
  • EVAX N/A
  • ADXN N/A
  • EPS Growth
  • EVAX N/A
  • ADXN N/A
  • EPS
  • EVAX N/A
  • ADXN 0.06
  • Revenue
  • EVAX $3,295,000.00
  • ADXN $701,260.00
  • Revenue This Year
  • EVAX $4,845.21
  • ADXN N/A
  • Revenue Next Year
  • EVAX $30.30
  • ADXN N/A
  • P/E Ratio
  • EVAX N/A
  • ADXN $1.04
  • Revenue Growth
  • EVAX N/A
  • ADXN N/A
  • 52 Week Low
  • EVAX $2.22
  • ADXN $6.81
  • 52 Week High
  • EVAX $23.70
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • ADXN 48.97
  • Support Level
  • EVAX $2.22
  • ADXN $7.20
  • Resistance Level
  • EVAX $4.05
  • ADXN $8.04
  • Average True Range (ATR)
  • EVAX 1.17
  • ADXN 0.51
  • MACD
  • EVAX 0.00
  • ADXN 0.00
  • Stochastic Oscillator
  • EVAX 6.99
  • ADXN 47.95

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: